221 related articles for article (PubMed ID: 33539510)
1. Altered linkage pattern of N-glycan sialic acids in pseudomyxoma peritonei.
Nummela P; Heiskanen A; Kytölä S; Haglund C; Lepistö A; Satomaa T; Ristimäki A
Glycobiology; 2021 Apr; 31(3):211-222. PubMed ID: 33539510
[TBL] [Abstract][Full Text] [Related]
2. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk.
Hegg KS; Mack LA; Bouchard-Fortier A; Temple WJ; Gui X
Ann Diagn Pathol; 2020 Oct; 48():151606. PubMed ID: 32889392
[TBL] [Abstract][Full Text] [Related]
4. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
6. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
Ronnett BM; Seidman JD
Am J Surg Pathol; 2003 May; 27(5):650-7. PubMed ID: 12717249
[TBL] [Abstract][Full Text] [Related]
7. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
8. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
[TBL] [Abstract][Full Text] [Related]
9. A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses.
Song X; Yu H; Chen X; Lasanajak Y; Tappert MM; Air GM; Tiwari VK; Cao H; Chokhawala HA; Zheng H; Cummings RD; Smith DF
J Biol Chem; 2011 Sep; 286(36):31610-22. PubMed ID: 21757734
[TBL] [Abstract][Full Text] [Related]
10. Sialylation of N-glycans: mechanism, cellular compartmentalization and function.
Bhide GP; Colley KJ
Histochem Cell Biol; 2017 Feb; 147(2):149-174. PubMed ID: 27975143
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid linkage-specific quantitative N-glycoproteomics using selective alkylamidation and multiplex TMT-labeling.
Yang H; Tian Z
Anal Chim Acta; 2022 Oct; 1230():340391. PubMed ID: 36192063
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
[TBL] [Abstract][Full Text] [Related]
15. A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm.
Sullivan BJ; Bolton N; Sarpel U; Magge D
World J Surg Oncol; 2019 Feb; 17(1):34. PubMed ID: 30777068
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
[TBL] [Abstract][Full Text] [Related]
17. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the α2-6 Sialic Acid Linkage in Branched N-Glycan Structures with Capillary Nanogel Electrophoresis.
Bwanali L; Crihfield CL; Newton EO; Zeger VR; Gattu S; Holland LA
Anal Chem; 2020 Jan; 92(1):1518-1524. PubMed ID: 31829566
[TBL] [Abstract][Full Text] [Related]
20. Structural and quantitative evidence of α2-6-sialylated N-glycans as markers of the differentiation potential of human mesenchymal stem cells.
Hasehira K; Hirabayashi J; Tateno H
Glycoconj J; 2017 Dec; 34(6):797-806. PubMed ID: 27314244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]